Lifeboat Foundation

Too bad the middle class is shrinking!

The rate of growth in residential rooftop solar photovoltaics (PV) in Australia since 2008 has been nothing short of breathtaking.

Our new research suggests that the households most likely to join in the solar spree are those that are affluent enough to afford the upfront investment, but not so wealthy that they don’t worry about their future power bills.

Continue reading “Are solar panels a middle-class purchase? This survey says yes” »

The idea of “healthy ageing” is a contradiction in terms.

Suppose you read the following sentence in an article about company management: “This factor is central in achieving successful bankruptcy.” It sounds rather weird, doesn’t it? What if you read this about football team training? “Contrary to popular belief, it is possible to lose a game in a successful way.” These are so-called oxymorons—by Oxford’s definition, “figures of speech in which apparently contradictory terms appear in conjunction.”

The contradictory nature of the statements above is more than just apparent—bankruptcy is the exact opposite of “success” for a company, and the same goes for losing a game for a football team. One can get very creative with these: “a blockbuster fiasco”; “the façade of the building deteriorated nicely”; and so on. Examples closer to home would be “healthy aging” or “aging gracefully”.

Continue reading “Getting sick in a healthy way” »

Really excited to announce our new initiative to make early-stage rejuvenation therapies more accessible.

Our mission is to enable people to vastly extend their healthy lifespan and be part of the first generation to cure aging.

We support the development of rejuvenation therapies that undo the damage of aging by funding basic research, bringing together the world’s leading scientists at our annual Undoing Aging conference and helping startups that work on actual therapies for human use.

Continue reading “Review current and up-coming rejuvenation therapies” »

Good news: The toolkit for neurorehabilitation is growing.

___ MindMaze Consolidates First-ever FDA Approval for Inpatient and Outpatient Neurorehabilitation Therapy (press release): MindMaze, a leader in braintech, has today announced that it has obtained FDA clearance to launch its portable neurorehabilitation product, MindMotion™ GO, in the United States. Together with.

Onstage at the launch of Amazon’s Alexa Prize, a multimillion-dollar competition to build AI that can chat like a human, the winners of last year’s challenge delivered a friendly warning to 2018’s hopefuls: your bot will mess up, it will say something offensive, and it will be taken offline. Elizabeth Clark, a member of last year’s champion Sounding Board team from the University of Washington, was onstage with her fellow researchers to share what they’d learned from their experience. What stuck out, she said, were the bloopers.

We were interested to learn that Juvenescence Limited, a biotech and development company involved in the development of therapies that target the aging processes, has successfully raised $50 million in a series A financing round.

Jim Mellon, the chairman of Juvenescence Limited, said, “We are delighted with the progress we have made and the faith that investors have placed in us to build a world-class company, one that we hope will lead the field in longevity science for the benefit of humanity as well as yield superb returns for our shareholders. Our company ethos is to advance the science that will add years of healthy life to every human being, and that is exactly what we are executing on at record speed.”

Juvenescence has raised $63 million from various international investors since its creation in October 2016 and is now moving forward with a number of key projects. The company is comprised of a number of industry leaders in business as well as a solid scientific team led by Dr. Declan Doogan and Dr. Annalisa Jenkins.

Continue reading “Juvenescence Completes $50 Million Series A Financing Round” »

But there’s a recent lesson worth learning from. Globalization and automation caused upheaval in the manufacturing industry from the 1980s through the early 2000s, and millions of factory workers lost their jobs. The disruption to communities is still being felt, and is arguably at the root of a lot of the biggest social and economic problems of this era.

Some big ideas are starting to percolate. But less dramatic ones might work, too.

Americans installed 2.5 gigawatts of solar panels in the first quarter of the year—a 13 percent increase from a year earlier, according to a report by the Solar Energy Industries Association. That made solar the leading source of new energy generation at 55 percent, dominating over wind and natural gas turbines. This was in spite of the fact that President Donald Trump imposed tariffs earlier this year on imported panels and their parts, reported Bloomberg News. Total installations are on track to reach 10.8 gigawatts at the end of the year, with installations reaching more than 14 gigawatts by 2023.

Read it at Bloomberg.

Neutrinos are so tiny and inconspicuous that physicists believed for a long time they had no mass. Now, a massive device that scientists say will determine the mass of neutrinos has begun operation in Karlsruhe.

What is the exact mass of the three known kinds of neutrinos? Any answers? No? Well, don’t worry, because nobody knows. Not yet. Electron, muon and tau neutrinos are simply too difficult to grasp for scientists.